Development of anti-drug monoclonal antibody panels against adalimumab and infliximab.

Suzuki, Takuo; Tada, Minoru; Ishii-Watabe, Akiko

Suzuki, Takuo; Tada, Minoru; Ishii-Watabe, Akiko.

Afiliação

Suzuki T; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kanagawa, Japan. Electronic address: tsuzuki@nihs.go.jp.
Tada M; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kanagawa, Japan.
Ishii-Watabe A; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kanagawa, Japan.

Biologicals ; 63: 39-47, 2020 Jan.

Article em En | MEDLINE | ID: mdl-31883741

Assuntos

Adalimumab; Anticorpos Neutralizantes; Infliximab; Adalimumab/química; Adalimumab/imunologia; Animais; Anticorpos Neutralizantes/química; Anticorpos Neutralizantes/imunologia; Células HEK293; Humanos; Infliximab/química; Infliximab/imunologia; Ratos

Palavras-chave

Adalimumab; Anti-drug antibody; Immunogenicity; Infliximab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Adalimumab / Infliximab Limite: Animals / Humans Idioma: En Revista: Biologicals Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google